on SARTORIUS STED BIO (EPA:DIM)
Sartorius Stedim Biotech General Meeting: Key Decisions
At the Combined General Meeting of Sartorius Stedim Biotech SA, held on March 24, 2026, in Aubagne, shareholders voted on key resolutions. They granted the directors a discharge for their term of office by a large majority. The Board of Directors will now include Michael Grosse, René Fáber, and other notable members.
Shareholders also approved the payment of a dividend of €0.69 per share for the 2025 financial year, totaling €67.1 million. The dividend payment will begin on April 2, 2026.
This meeting confirms the financial calendar with the first quarterly publication scheduled for April 23, 2026.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SARTORIUS STED BIO news